z-logo
Premium
Gene expression dynamics following mithramycin treatment: A possible model for post‐chemotherapy cognitive impairment
Author(s) -
Asor Eyal,
BenShachar Dorit
Publication year - 2018
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/1440-1681.12975
Subject(s) - gene expression , chemotherapy , prefrontal cortex , gene , biology , endocrinology , cortex (anatomy) , medicine , cognition , physiology , psychology , neuroscience , genetics
Summary Chemotherapy‐induced cognitive changes is a major burden on a substantial number of cancer survivors. The mechanism of this sequel is unknown. In this study, we followed long‐term effects of early in life mithramycin ( MTR ) treatment on behaviour and on the normal course of alterations of gene expression in brain. Between post‐natal days ( PND ) 7 and 10, male rats were divided into 2 groups, 1 receiving MTR (0.1 mg/kg s.c. per day) and the other receiving saline. At PND 11, frontal cortex tissue samples were dissected from 4 rats from each group. At PND 65 the remaining rats underwent behavioural tests after which all the rats were decapitated and their prefrontal cortex incised. Rats treated transiently with MTR early in life, showed impairments in spatial working memory and anxious‐like behaviour in adulthood. The immediate molecular effect of MTR was expressed in a limited number of altered genes of different unconnected trajectories, which were simultaneously distorted by the drug. In contrast, 3 months later we observed a change in the expression of more than 1000 genes that converged into specific cellular processes. Time‐dependent gene expression dynamics of several genes was significantly different between treated and untreated rats. The differences in the total number of altered genes and in gene expression trends, immediately and long after MTR treatment cessation, suggest the evolution of a new cellular homeostatic set point, which can lead to behavioural abnormalities following chemotherapy treatment.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here